SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Keene Kathleen M.

(Last) (First) (Middle)
C/O INGERSOLL RAND INC.
800-A BEATY STREET

(Street)
DAVIDSON NC 28036

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/22/2021
3. Issuer Name and Ticker or Trading Symbol
Ingersoll Rand Inc. [ IR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 813 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Common Stock 387 (1) D
Restricted Stock Units (2) (2) Common Stock 966 (2) D
Restricted Stock Units (3) (3) Common Stock 767 (3) D
Stock Options (Right to Buy) (4) 02/05/2028 Common Stock 2,665 $23.08 D
Stock Options (Right to Buy) (5) 02/04/2029 Common Stock 4,629 $25.96 D
Stock Options (Right to Buy) (6) 03/25/2030 Common Stock 3,325 $23.28 D
Stock Options (Right to Buy) (7) 02/23/2031 Common Stock 1,945 $45.58 D
Explanation of Responses:
1. Represents unvested restricted stock units which will vest on February 5, 2022 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
2. Represents unvested restricted stock units which will vest in three equal annual installments on March 25, 2022, 2023 and 2024 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
3. Represents unvested restricted stock units which will vest in four equal annual installments on February 23, 2022, 2023, 2024 and 2025 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.
4. These options are fully vested and exercisable.
5. Represents stock options granted on February 5, 2019 of which 2,315 are unvested and will vest on February 5, 2022.
6. Represents stock options granted on March 25, 2020 and will vest in three equal annual installments beginning on the first anniversary of the grant date.
7. Represents stock options granted on February 23, 2021 which vest in four equal annual installments beginning on the first anniversary of the grant date.
Remarks:
Title: Senior Vice President, Human Resources, Talent, and Diversity, Equity and Inclusion. Exhibit List: Exhibit 24 - Power of Attorney.
/s/ Andrew Schiesl, Attorney-in-Fact 07/02/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.